CALL - SPRINTER OPEN END - EDWARDS LIFESCIENCES | Real-time Boerse Frankfurt Warrants 04:23:25 2024-06-11 am EDT | ||
| 0.22 EUR | -4.35% |
|
| Current month | -17.86% | ||
| 1 month | -34.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-11 | 0.22 | -4.35% |
| 24-06-10 | 0.23 | -39.47% |
| 24-06-07 | 0.38 | -5.00% |
| 24-06-06 | 0.4 | +14.29% |
| 24-06-05 | 0.35 | -7.89% |
Real-time Boerse Frankfurt Warrants
Last update June 11, 2024 at 04:23 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD5H4H |
| ISIN | DE000VD5H4H9 |
| Date issued | 2024-05-03 |
| Strike | 83.79 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.73 € |
|---|---|
| Lowest since issue | 0.16 € |
| Spread | 0.04 € |
| Spread % | 16.00% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.1
USD
Average target price
96.31
USD
Spread / Average Target
+11.86%
- Stock Market
- Certificates
- Certificat
